Home › Compare › PEARW vs ORCC

PEARW vs ORCC: Dividend Comparison 2026

PEARW yields 33898.31% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PEARW wins by $9.963396520724352e+21M in total portfolio value
10 years
PEARW
PEARW
● Live price
33898.31%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$9.963396520724352e+21M
Annual income
$9,905,911,559,981,649,000,000,000,000.00
Full PEARW calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — PEARW vs ORCC

📍 PEARW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPEARWORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PEARW + ORCC cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
PEARW pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PEARW
Annual income on $10K today (after 15% tax)
$2,881,355.93/yr
After 10yr DRIP, annual income (after tax)
$8,420,024,825,984,401,000,000,000,000.00/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, PEARW beats the other by $8,420,024,825,984,401,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PEARW + ORCC for your $10,000?

PEARW: 50%ORCC: 50%
100% ORCC50/50100% PEARW
Portfolio after 10yr
$4.981698260362176e+21M
Annual income
$4,952,955,779,990,824,000,000,000,000.00/yr
Blended yield
99.42%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

PEARW
No analyst data
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PEARW buys
0
ORCC buys
0
No recent congressional trades found for PEARW or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPEARWORCC
Forward yield33898.31% ✓9.79%
Annual dividend / share$2.00 ✓$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0% ✓-50%
Portfolio after 10y$9.963396520724352e+21M$21.4K ✓
Annual income after 10y$9,905,911,559,981,649,000,000,000,000.00 ✓$1.04
Total dividends collected$9.959616773768018e+21M ✓$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: PEARW vs ORCC ($10,000, DRIP)

YearPEARW PortfolioPEARW Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$3,400,531$3,389,830.51$11,190$489.61+$3.39M → PEARW
2$1,080,949,041$1,077,310,473.14$12,229$256.01+$1080.94M → PEARW
3$321,205,007,173$320,048,391,699.27$13,216$130.74+$321204.99M → PEARW
4$89,224,694,578,678$88,881,005,221,002.70$14,207$66.02+$89224694.56M → PEARW
5$23,169,738,996,241,900$23,074,268,573,042,710.00$15,234$33.17+$23169738996.23M → PEARW
6$5,624,691,175,493,529,000$5,599,899,554,767,550,000.00$16,317$16.62+$5624691175493.51M → PEARW
7$1,276,516,462,323,700,300,000$1,270,498,042,765,922,300,000.00$17,468$8.32+$1276516462323700.25M → PEARW
8$270,840,549,707,403,520,000,000$269,474,677,092,717,130,000,000.00$18,695$4.16+$270840549707403520.00M → PEARW
9$53,724,262,376,359,350,000,000,000$53,434,462,988,172,430,000,000,000.00$20,006$2.08+$53724262376359346176.00M → PEARW
10$9,963,396,520,724,353,000,000,000,000$9,905,911,559,981,649,000,000,000,000.00$21,407$1.04+$9.963396520724352e+21M → PEARW

PEARW vs ORCC: Complete Analysis 2026

PEARW — Stock

Pear Therapeutics, Inc. engages in developing and commercializing software-based medicines. The company has a pipeline of products and product candidates across therapeutic areas, including severe psychiatric and neurologic conditions. Its products include PearConnect, a patient service center for prescription digital therapeutics; reSET for the treatment of substance use disorder; reSET-O for the treatment of opioid use disorder; and Somryst for the treatment of chronic insomnia. The company was founded in 2013 and is based in Boston, Massachusetts.

Full PEARW Calculator →

ORCC — BDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this PEARW vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PEARW vs SCHDPEARW vs JEPIPEARW vs OPEARW vs KOPEARW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.